Antibiotic :: FDA restricts use of Sanofi-Aventis’ antibiotic Ketek
The US Federal regulators – FDA has narrowed the approved uses and indications of the controversial Sanofi-Aventis’ antibiotic Ketek.
The US Federal regulators – FDA has narrowed the approved uses and indications of the controversial Sanofi-Aventis’ antibiotic Ketek.
In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the NIAID have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody. Unlike much of the constantly mutating virus, this protein component is stable and — more importantly, say the researchers — appears vulnerable to attack from this specific antibody, known as b12, that can broadly neutralize HIV.
The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic Ketek (telithromycin) designed to improve the safe use of Ketek by patients.
Half the people experiencing stroke symptoms ? especially those with lower incomes ? don?t seek medical treatment, researchers reported at the American Stroke Association?s International Stroke Conference 2007.
A robotic therapy device may help people regain strength and normal use of affected hands long after a stroke, according to a University of California, Irvine study.
Instead of dismissing grumblings about being tired or exhausted, people should take these complaints seriously before they lead to a worsened health state or even death, says a University of Alberta researcher investigating fatigue.
Kenya health officials are trying to stop the spread of Rift Valley Fever, which has killed more than 600 people. In Northern Kenya it killed 478 people, and 148 through out the nation.
Multiple sclerosis (MS) is a chronic inflammatory disorder that causes degeneration of the nerves in the brain and spinal cord, leading to various symptoms including muscle weakness and pain.
A new strategy for fighting cancer aims to make its genes get lost in translation, according to a report in the Jan. 26, 2007, issue of the journal Cell, published by Cell Press.
For migraine sufferers who don’t benefit from current migraine medications, hope may come from a new clinical trial, conducted in part at Washington University School of Medicine in St. Louis. The trial offers an unexpected solution ? doctors are closing a hole in the heart to try to fix the ache in the head.